RxDoctor Payments Data

Steven Barker, PA

Physician Assistant · Taylorsville, UTNPI 1083387732

Payments from drug & device makers

$790in general payments, 2019–2025

Across 37 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$157
  • AstraZeneca$151
  • Boston Scientific$118
  • Novo Nordisk$96
  • AbbVie$49
  • Sanofi-aventis U.S. LLC$40
  • plus $178 from 8 others

What the payments were for

  • Food & beverage$790100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$790 in reported general payments places this provider in the 65th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$43,629
Medicare patients
82
Services billed
547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide29$45,674
MounjaroTirzepatide36$40,770
EliquisApixaban27$27,704
TradjentaLinagliptin17$10,889
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,791
JanuviaSitagliptin Phosphate12$8,790
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$2,855
Albuterol Sulfate HfaAlbuterol Sulfate53$1,813
Omeprazole93$1,726
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst25$1,450
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$1,408
Gabapentin84$1,325
Atorvastatin Calcium142$1,204
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,159
Pregabalin53$1,068

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$96$45,67429 claims
Lilly USA, LLCMounjaro$157$40,77036 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Taylorsville

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →